Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $138.1 million.

  • Pediatrix Medical's Cash from Operations rose 3712.77% to $138.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $294.9 million, marking a year-over-year increase of 8973.55%. This contributed to the annual value of $217.2 million for FY2024, which is 4871.89% up from last year.
  • Latest data reveals that Pediatrix Medical reported Cash from Operations of $138.1 million as of Q3 2025, which was up 3712.77% from $139.5 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Cash from Operations registered a high of $139.5 million during Q2 2025, and its lowest value of -$125.2 million during Q1 2024.
  • For the 5-year period, Pediatrix Medical's Cash from Operations averaged around $43.1 million, with its median value being $82.4 million (2022).
  • The largest annual percentage gain for Pediatrix Medical's Cash from Operations in the last 5 years was 73241.19% (2021), contrasted with its biggest fall of 7524.92% (2021).
  • Quarter analysis of 5 years shows Pediatrix Medical's Cash from Operations stood at $75.0 million in 2021, then skyrocketed by 36.31% to $102.3 million in 2022, then dropped by 28.63% to $73.0 million in 2023, then skyrocketed by 84.66% to $134.8 million in 2024, then increased by 2.46% to $138.1 million in 2025.
  • Its Cash from Operations stands at $138.1 million for Q3 2025, versus $139.5 million for Q2 2025 and -$117.5 million for Q1 2025.